zli12321/Bills huggingface dataset:
Prescription Drug Abuse Prevention and Treatment Act of 2013 - Amends the Public Health Service Act to direct the Administrator of the Substance Abuse and Mental Health Services Administration to award grants to states and nonprofit entities for consumer education about opioid abuse, including methadone abuse.

Amends the Controlled Substances Act to: (1) set forth training requirements for practitioners registered to prescribe or dispense methadone or other opioids, and (2) require each registered opioid treatment clinic to make acceptable arrangements for each patient who is restricted from having a take-home dose of a controlled substance related to treatment to receive a dose of that substance under appropriate supervision when the clinic is closed.

Prohibits any individual or entity (except hospitals that provide direct patient supervision) from prescribing or dispensing a 40-mg diskette of methadone unless such prescription or dispensation is consistent with the current Drug Enforcement Administration (DEA) methadone policy, until the date the Controlled Substances Clinical Standards Commission: (1) publishes dosing guidelines for methadone, and (2) finds that such 40-mg diskettes are safe and clinically appropriate. Requires the Secretary of Health and Human Services (HHS) to establish such Commission to develop and publish guidelines related to methadone use, including safe dosing guidelines for all forms of methadone and benchmark guidelines for the reduction of methadone abuse.

Requires states receiving controlled substances monitoring program grants to: (1) provide information, upon request, to drug enforcement officials relating to an individual who is the subject of an active drug-related investigation; and (2) require opioid-related deaths to be reported to the Administrator.

Directs the Administrator to develop a Model Opioid Treatment Program Mortality Report.

Requires the Administrator to establish and implement, through the National Center for Health Statistics, a National Opioid Death Registry to track opioid-related deaths.

Requires the Secretary, acting through the Director of the Agency for Healthcare Research and Quality (AHRQ), to require the development and application of specific prescription drug abuse prevention and treatment quality measures for each relevant health care provider setting.

Date: 2013-02-13
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Access to Substance Abuse Treatment Act of 2013 - Amends the Public Health Service Act to authorize the Secretary of Health and Human Services (HHS) to make grants to: (1) increase the availability of treatment for abuse of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP); (2) provide vouchers to individuals in underserved populations for authorized services related to such treatment; and (3) establish programs to provide for and coordinate the provision of wrap-around services, such as medical services, job training services, and housing assistance, to individuals re-entering the community after successfully receiving treatment for abuse of such substances.

Revises the grant program to provide residential substance abuse treatment to pregnant and postpartum women to: (1) make caregiver parents eligible for such program, (2) make Indian tribes and tribal organizations eligible for grants, and (3) set forth the priority for allocation of grants.

Requires the Director of the National Institute on Drug Abuse to conduct research on the effectiveness of the use of agonist and antagonist drugs to reduce the problems associated with stimulant abuse, including cocaine and methamphetamine abuse.

Requires the Secretary to seek to enter into a contract with the Institute of Medicine to complete a literature review on the effectiveness of agonist and antagonist drugs for the treatment of stimulant abuse, including cocaine and methamphetamine abuse.

Requires the Comptroller General to study: (1) the impact of the programs authorized by this Act on the effectiveness and availability of treatment for abuse of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and phencyclidine; (2) how the level of federal funding available for such treatment compares to the amount necessary to provide adequate treatment; and (3) the impact of effective treatment on cost savings due to the reduced need for criminal justice and other services.

 Declares that this Act shall not be construed to increase the amount of appropriations that are authorized to be approved for any fiscal year.

Date: 2013-05-23
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Synthetics are Dangerous Act of 2013 - Amends the Office of National Drug Control Policy Reauthorization Act of 1998 to: (1) include among the purposes of the national youth anti-drug media campaign to encourage parents and other interested adults to discuss with young people the dangers of synthetic drug use; (2) define "drug" for purposes of such campaign to be a controlled substance, including a synthetic drug; and (3) define a "synthetic drug" as an artificially produced substance that is an analog or derivative of a controlled substance but is not itself a controlled substance.

Date: 2013-05-23
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Promoting Integrity in Medicare Act of 2013 - Amends title XVIII (Medicare) of the Social Security Act (SSA) with respect to the general exceptions to both ownership and compensation arrangement prohibitions against physician self-referrals of Medicare patients to the entity with which a physician has a certain financial relationship.

Removes from the in-office ancillary services (IOAS) exception to such prohibitions certain services the Secretary of Health and Human Services (HHS) determines are not usually provided and completed during the visit to a physician's office in which such a service is determined to be necessary (non-ancillary services). (Thus subjects such non-ancillary services to the prohibitions against physician self-referrals).

Lists among specified non-ancillary services: (1) anatomic pathology services (including the technical or professional component of surgical pathology, cytopathology, hematology, blood banking, and pathology consultation and clinical laboratory interpretation services), (2) radiation therapy services and supplies, (3) advanced diagnostic imaging studies, and (4) physical therapy services.

Increases from a maximum of $15,000 to a maximum of $25,000 the civil monetary penalty in the case of a bill or claim for such services whose presenter knows or should have known they are for a service for which payment may not be made.

Increases from a maximum of $100,000 to a maximum of $150,000 the civil monetary penalty for any circumventive arrangement or scheme which a physician or other entity enters into knowing (or should know) has a principal purpose of assuring referrals by the physician to a particular entity which, if the physician directly made referrals to such entity, would be in violation of SSA title XVIII.

Directs the Secretary to review compliance with the self-referral prohibitions with respect to referrals for specified non-ancillary services in accordance with procedures established by the Secretary.

States that, in applying the self-referral prohibitions, the term "entity" includes a physician's practice when it bills under Medicare for the technical component or the professional component of a specified non-ancillary service.

Date: 2013-08-01
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Ensuring Quality in the Unemployment Insurance Program (EQUIP) Act - Amends title III (Grants to States for Unemployment Compensation Administration) of the Social Security Act (SSA) to require state unemployment compensation (UC) laws to require, as a condition of UC eligibility for a benefit year, an applicant, before receiving any UC, to: (1) complete a substance abuse risk assessment; and (2) test negative for controlled substances within one week after the results of such assessment if the state determines that the applicant is a high-risk. Prescribes retesting requirements and UC payment suspensions for applicants who test positive.

Amends SSA title XVIII (Medicare) and the Patient Protection and Affordable Care Act to provide funding for such substance abuse testing out of current funds appropriated for the Independent Payment Advisory Board (IPAB) and, after application of those funds, for the Consumer Operated and Oriented Plan (CO-OP) program.

Date: 2013-11-12
Topic: Health (Drug and Alcohol Abuse)
Subject: Labor and employment
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2013 - Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of such Act to foster the establishment of state-administered controlled substance monitoring systems in order to ensure that appropriate law enforcement, regulatory, and state professional licensing authorities have access to prescription history information for the purposes of investigating drug diversion and prescribing and dispensing practices of errant prescribers or pharmacists.

Amends the Public Health Service Act to revise and update the controlled substance monitoring program, including to: (1) allow grants to be used to maintain and operate existing state controlled substance monitoring programs, (2) require the Secretary of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, (3) require a state to provide the Secretary with aggregate data and other information to enable the Secretary to evaluate the success of the state's program and to submit a progress report to Congress, and (4) expand the program to include any commonwealth or territory of the United States.

Authorizes the Drug Enforcement Administration (DEA) or a state Medicaid program or state health department receiving nonidentifiable information from a controlled substance monitoring database to make such information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber use of the state's controlled substance monitoring system, and (2) educate prescribers on the benefits of the system both to them and society.

Revises preferences for grants related to drug abuse to authorize the Secretary to give preference to eligible states or tribes that put forth a good faith effort to meet minimum requirements under the controlled substance monitoring program.

Date: 2013-11-18
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Amends the Safe and Drug-Free Schools and Communities Act to require: (1) states to use grants for safe and drug-free schools to collect and report information on the incidence of bullying and harassment, and (2) local educational agencies (LEAs) and schools to use subgrants to prevent and respond to incidents of bullying and harassment.

Requires such LEAs or schools to: (1) notify parents and students annually of conduct prohibited in their school discipline policies, that now must include bullying and harassment; and (2) establish complaint procedures for students and parents to register complaints regarding such conduct.

Includes bullying and harassment within the Act's definition of violence.

Date: 2014-01-16
Topic: Health (Drug and Alcohol Abuse)
Subject: Education
Preventing Abuse of Cough Treatments Act of 2014 or the PACT Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale or offering for sale of a drug containing dextromethorphan, and not subject to practitioner supervision requirements, to an individual under age 18, except if the sale is made: (1) pursuant to a validly issued prescription; or (2) to an individual who provides proof of being actively enrolled in the military, including a valid military identification card. Imposes civil monetary penalties that escalate upon repeated violation.

Deems to be adulterated any unfinished dextromethorphan that is possessed, received, or distributed in violation of this Act. Prohibits a person from: (1) possessing or receiving unfinished dextromethorphan unless the person is registered with the Secretary of Health and Human Services (HHS) as a producer of a drug or device or otherwise registered, licensed, or approved under federal or state law to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients; or (2) distributing unfinished dextromethorphan to any person other than a registered or otherwise authorized person. Excludes from such prohibitions common carriers that possess, receive, or distribute unfinished dextromethorphan for purposes of distributing it between registered, licensed, or approved persons. Imposes additional civil monetary penalties for such possession and distribution violations.

Date: 2014-01-29
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Stop Overdose Stat Act or the S.O.S. Act - Requires the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) award grants or enter into cooperative agreements to enable eligible entities to reduce deaths occurring from drug overdoses, and (2) give priority to eligible public health agencies or community-based organizations that have expertise in preventing deaths occurring from overdoses in high risk populations.

Conditions receipt of a grant or agreement on an entity agreeing to: (1) use it for purchasing and distributing the drug naloxone, (2) report to the Secretary and the coordinating center (established under this Act) on the results of the activities supported, and (3) make available non-federal contributions of at least 50% of the federal funds provided. Requires a recipient to use such grant or agreement for: (1) educating prescribers and pharmacists about overdose prevention and naloxone prescription; (2) training first responders, other individuals in a position to respond to an overdose, and law enforcement and corrections officials on the effective response to individuals who have overdosed on drugs; (3) implementing and enhancing programs to provide overdose prevention, recognition, treatment, and response; and/or (4) expanding such activities.

Requires the Director to establish and provide for the operation of a coordinating center responsible for: (1) collecting, compiling, disseminating, and evaluating data on such activities; (2) developing best practices for preventing deaths occurring from drug overdoses; and (3) making such best practices specific to the type of community involved.

Requires the Director to award grants or cooperative agreements to improve drug overdose surveillance and reporting capabilities.

Amends the Public Health Service Act to require the Secretary to develop and submit to Congress a plan to reduce the number of deaths occurring from overdoses, to include implementation of a campaign to educate prescribers and the public about overdose prevention and naloxone prescription.

Requires the Director of the National Institute on Drug Abuse to: (1) prioritize and conduct or support research on drug overdose and overdose prevention, and (2) support research on the development of formulations of naloxone and dosage delivery devices specifically intended to be used for the prehospital treatment of unintentional drug overdose.

Date: 2014-03-06
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Opioid Overdose Reduction Act of 2014 - Exempts from liability for harm caused by the emergency administration of an opioid overdose drug:

 a health care professional who prescribes or provides such a drug to an individual at risk of experiencing an opioid overdose, or to another person in a position to assist such individual, if the individual has been educated about opioid overdose prevention and treatment by the health care professional or as part of a government opioid overdose program; a person who provides such a drug for emergency administration to an individual authorized to receive it as part of an opioid overdose program; and a person who provides for emergency administration of such a drug to an individual who reasonably appears to have suffered an overdose from heroin or another opioid if such person obtained such drug from a health care professional or as part of an opioid overdose program and was educated by such professional or program in the proper administration of such drug. Makes such exemptions inapplicable if the harm was caused by gross negligence or reckless misconduct.

Date: 2014-03-24
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Expanding Opportunities for Recovery Act of 2014 - Requires the Administrator of the Substance Abuse and Mental Health Services Administration to award grants to states to expand access to clinically appropriate services for opioid abuse or addiction. Requires states to use these grants to provide up to 60 consecutive days of services to individuals who otherwise would not have access to substance abuse services.

Date: 2014-07-31
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Opioid Abuse Prevention and Treatment Act of 2014 - Requires the Secretary of Health and Human Services (HHS) to award grants to states to develop a peer review process to identify and investigate questionable or inappropriate prescribing and dispensing patterns of drugs classified as schedule II or III under the Controlled Substances Act, which are drugs with an accepted medical use that have the potential to be abused and addictive.

Amends the Public Health Service Act to require the Secretary to establish grant programs to: (1) facilitate training to increase the capacity of health care providers to screen and treat patients to prevent drug abuse, and (2) develop continuing education criteria that allow health profession boards or state agencies to certify appropriate education for safe prescribing of schedule II or III drugs. Requires the Administrator of the Health Resources and Services Administration to award grants to evaluate the prospect of state health professions boards expanding the authority of providers to prescribe drugs to treat drug abuse.

Requires the Attorney General to request that practitioners registered to dispense controlled substances screen patients for potential drug abuse before prescribing a schedule II or III drug.

Directs the Food and Drug Administration (FDA) to consider whether naloxone (a prescription drug used to rapidly reverse an overdose of heroin or other opioids, which are drugs with effects similar to opium) should be available without a prescription.

Requires the Secretary to use an interagency working group to encourage states and local governments to increase opportunities for disposal of opiates (drugs derived from opium) and to reduce opportunities for abuse of opiates.

Requires the Government Accountability Office (GAO) to review federal opioid abuse activities and make recommendations to reduce opioid abuse and overdoses.

Date: 2014-09-18
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Veterans Equal Access Act of 2014 - Directs the Secretary of Veterans Affairs (VA) to authorize VA health care providers to: (1) provide veterans with recommendations and opinions regarding participation in their state's marijuana programs, and (2) complete forms reflecting such recommendations and opinions.

Date: 2014-11-20
Topic: Health (Drug and Alcohol Abuse)
Subject: Armed forces and national security
Advancing FASD Research, Prevention, and Services Act - Amends the Public Health Service Act to revise and extend the Fetal Alcohol Spectrum Disorders (FASD) programs (as renamed under this Act, previously the Fetal Alcohol Syndrome and Fetal Alcohol Effect programs). Directs the Secretary of Health and Human Services (HHS) to: (1) establish and carry out a research agenda for FASD; (2) facilitate surveillance, public health research, and prevention of FASD; and (3) continue the Interagency Coordinating Committee on Fetal Alcohol Syndrome.

Requires the Secretary to provide financial assistance to: (1) establish or expand state FASD programs; (2) implement best practices to educate children with FASD, educate members of the criminal justice system on FASD, and educate adoption or foster care agency officials about services for children with FASD; (3) provide transitional services for those affected by prenatal alcohol exposure; (4) develop public service announcements to raise awareness of the risks associated with alcohol consumption during pregnancy; (5) increase awareness and identification of FASD in federally qualified health centers; and (6) provide respite care for caretakers, recruit mentors, and provide educational and supportive services to families of individuals with FASD.

Directs the Comptroller General (GAO) to make recommendations regarding the appropriate roles and responsibilities of federal entities with respect to programs and activities related to FASD.

Requires the Secretary of Education to direct the Office of Special Education and Rehabilitative Services to conduct training on FASD surveillance and disseminate best practices in the education and support of children with FASD.

Requires the Attorney General (DOJ) to direct the Office of Juvenile Justice and Delinquency Prevention to: (1) implement FASD screening procedures, (2) conduct training on surveillance and on identification and support of individuals with FASD, and (3) study the inadequacies of the current system.

Date: 2013-02-07
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Prescription Drug Abuse Prevention and Treatment Act of 2013 - Amends the Public Health Service Act to direct the Administrator of the Substance Abuse and Mental Health Services Administration to award grants to states and nonprofit entities for consumer education about opioid abuse, including methadone abuse.

Amends the Controlled Substances Act to: (1) set forth training requirements for practitioners registered to prescribe or dispense methadone or other opioids, and (2) require each registered opioid treatment clinic to make acceptable arrangements for each patient who is restricted from having a take-home dose of a controlled substance related to treatment to receive a dose of that substance under appropriate supervision when the clinic is closed.

Prohibits any individual or entity (except hospitals that provide direct patient supervision) from prescribing or dispensing a 40-mg diskette of methadone unless such prescription or dispensation is consistent with the current Drug Enforcement Administration (DEA) methadone policy, until the date the Controlled Substances Clinical Standards Commission: (1) publishes dosing guidelines for methadone, and (2) finds that such 40-mg diskettes are safe and clinically appropriate. Requires the Secretary of Health and Human Services (HHS) to establish such Commission to develop and publish guidelines related to methadone use, including safe dosing guidelines for all forms of methadone and benchmark guidelines for the reduction of methadone abuse.

Requires states receiving controlled substances monitoring program grants to: (1) provide information, upon request, to drug enforcement officials relating to an individual who is the subject of an active drug-related investigation; and (2) require opioid-related deaths to be reported to the Administrator.

Directs the Administrator to develop a Model Opioid Treatment Program Mortality Report.

Requires the Administrator to establish and implement, through the National Center for Health Statistics, a National Opioid Death Registry to track opioid-related deaths.

Requires the Secretary, acting through the Director of the Agency for Healthcare Research and Quality (AHRQ), to require the development and application of specific prescription drug abuse prevention and treatment quality measures for each relevant health care provider setting.

Date: 2013-02-14
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Preventing Abuse of Cough Treatments Act of 2013 or PACT Act - Amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale or offering for sale of a drug containing dextromethorphan, and not subject to practitioner supervision requirements, to an individual under age 18, except if the sale is made: (1) pursuant to a validly issued prescription; or (2) to an individual who provides proof of being actively enrolled in the military, including a valid military identification card. Imposes civil monetary penalties that escalate upon repeated violation.

Deems to be adulterated any unfinished dextromethorphan that is possessed, received, or distributed in violation of this Act. Prohibits a person from: (1) possessing or receiving unfinished dextromethorphan unless the person is registered with the Secretary of Health and Human Services (HHS) as a producer of a drug or device or otherwise registered, licensed, or approved under federal or state law to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients; or (2) distributing unfinished dextromethorphan to any person other than a registered or otherwise authorized person. Excludes from such prohibitions common carriers that possess, receive, or distribute unfinished dextromethorphan for purposes of distributing it between registered, licensed, or approved persons. Imposes additional civil monetary penalties for such possession and distribution violations.

Date: 2013-03-21
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Combating Prescription Drug Abuse Act - Establishes the Combating Prescription Drug Abuse Commission, whose duties shall be to: (1) review and report to Congress on federal initiatives regarding efforts to prevent and reduce prescription drug abuse, (2) identify gaps and opportunities regarding the safe use of prescription drugs with the potential for diversion and abuse, and (3) make recommendations on specific ways to reduce diversion and abuse of prescription drugs.

Requires the report to describe Commission efforts to prevent or reduce drug diversion and abuse to ensure that patients continue to have access to medications and include specific recommendations for the Drug Enforcement Administration (DEA), the Food and Drug Administration (FDA), and other federal and state agencies concerning prescription drug monitoring and abuse.

Date: 2013-07-10
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Opioid Overdose Reduction Act of 2014 - Exempts from liability for harm caused by the emergency administration of an opioid overdose drug:

 a health care professional who prescribes or provides such a drug to an individual at risk of experiencing an opioid overdose, or to another person in a position to assist such individual, if the individual has been educated about opioid overdose prevention and treatment by the health care professional or as part of a government opioid overdose program; a person who provides such a drug for emergency administration to an individual authorized to receive it as part of an opioid overdose program; and a person who provides for emergency administration of such a drug to an individual who reasonably appears to have suffered an overdose from heroin or another opioid if such person obtained such drug from a health care professional or as part of an opioid overdose program and was educated by such professional or program in the proper administration of such drug. Makes such exemptions inapplicable if the harm was caused by gross negligence or reckless misconduct.

Date: 2014-03-06
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014 - Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of such Act to foster the establishment of state-administered controlled substance monitoring systems in order to ensure that appropriate law enforcement, regulatory, and state professional licensing authorities have access to prescription history information for the purposes of investigating drug diversion and prescribing and dispensing practices of errant prescribers or pharmacists.

 Amends the Public Health Service Act to revise and update the controlled substance monitoring program, including to:

 allow grants to be used to maintain and operate existing state controlled substance monitoring programs, require submission by a state of a plan to apply the latest advances in health information technology to incorporate prescription drug monitoring program data directly into the workflow of prescribers and dispensers, require timelines and descriptions for implementation of interoperability for purposes of information sharing with a bordering state that already operates a monitoring program, require health information interoperability standards to be consistent with at least one health information technology system, require the Secretary of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, require a state to provide the Secretary with aggregate data and other information to enable the Secretary to evaluate the success of the state's program and to submit a progress report to Congress, and expand the program to include any commonwealth or territory of the United States. Authorizes the Drug Enforcement Administration (DEA) or a state Medicaid program or health department receiving nonidentifiable information from a controlled substance monitoring database to make such information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.

 Removes the preferences for grants related to drug abuse for states with approved applications to implement controlled substances monitoring programs.

Revises requirements for studies on progress to include assessment of the effects upon linkages to substance abuse disorder services and interoperability with health information technology systems.

Date: 2014-06-25
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Overdose Prevention Act - Amends the Public Health Service Act to require the Director of the Centers for Disease Control and Prevention (CDC) to enter into cooperative agreements to reduce deaths from drug overdoses by: (1) purchasing and distributing naloxone (a medication that rapidly reverses overdose from heroin or other opioids, which are drugs with effects similar to opium) or a similar drug; and (2) educating or training the public, first responders, or health professionals on drug overdose prevention or response. Requires the CDC to improve drug overdose surveillance by entering into cooperative agreements to: (1) provide training to improve identification of drug overdose as the cause of death, and (2) establish a national program for reporting drug overdoses.

Directs the Secretary of Health and Human Services (HHS) to establish a coordinating center and develop a plan to reduce drug overdose deaths by educating the public about overdose prevention and recommending improvements to overdose prevention programs.

Requires the Director of the National Institute on Drug Abuse (NIDA) to prioritize, conduct, and support research on circumstances that contribute to drug overdose, drugs associated with fatal overdose, and overdose prevention methods. Directs NIDA to support research on drug overdose treatments that can be administered by lay persons or first responders.

Date: 2014-07-31
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Sober Truth on Preventing Underage Drinking Reauthorization Act or STOP Act - Amends the Public Health Service Act to reauthorize the program to reduce underage drinking for FY2015-FY2018.

Revises reporting requirements for state programs on underage drinking.

 Specifies additional requirements for the development of the national media campaign to prevent underage drinking.

Directs the Administrator of the Substance Abuse and Mental Health Services Administration to make grants to professional pediatric provider organizations to increase effective practices, including the screening of children and adolescents for alcohol use, to reduce the prevalence of alcohol use among individuals under the age of 21, including college students.

Directs the Secretary of Health and Human Services (HHS) to collect data and conduct or support new research on underage drinking that improves and conducts public health surveillance of alcohol use and alcohol-related conditions in states among individuals between age 18 and 20 by increasing the use of surveys, such as the Behavioral Risk Factor Surveillance System, to monitor binge and excessive drinking and related harms.

Amends the Federal Alcohol Administration Act to prohibit the manufacture, sale, distribution, or possession of powdered alcohol.

Date: 2014-11-17
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Veterans Equal Access Act

Directs the Secretary of Veterans Affairs (VA) to authorize VA health care providers to: (1) provide veterans with recommendations and opinions regarding participation in their state's marijuana programs, and (2) complete forms reflecting such recommendations and opinions.

Date: 2015-02-03
Topic: Health (Drug and Alcohol Abuse)
Subject: Armed forces and national security
Sober Truth on Preventing Underage Drinking Reauthorization Act or the STOP Act

Amends the Public Health Service Act to reauthorize the program to reduce underage drinking for FY2016-FY2020.

Revises reporting requirements for state programs on underage drinking.

 Specifies additional requirements for the development of the national media campaign to prevent underage drinking.

Directs the Substance Abuse and Mental Health Services Administration to make grants to professional pediatric provider organizations to increase effective practices, including the screening of children and adolescents for alcohol use, to reduce the prevalence of alcohol use among individuals under the age of 21, including college students.

Directs the Department of Health and Human Services to collect data and conduct or support new research on underage drinking that carries out and improves public health surveillance of alcohol use and alcohol-related conditions in states among individuals between age 18 and 20 by increasing the use of surveys, such as the Behavioral Risk Factor Surveillance System, to monitor binge and excessive drinking and related harms.

Date: 2015-03-26
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

(Sec. 2) Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities.

 (Sec. 3) Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to:

 allow grants to be used to maintain and operate existing state controlled substance monitoring programs, require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and expand the program to include any commonwealth or territory of the United States. Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes to make that information available to other entities for research purposes.

Requires a state receiving a grant to: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system both to them and society.

Date: 2015-03-26
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Opioid Overdose Reduction Act of 2015

This bill exempts individuals from liability for harm caused by the emergency administration of an opioid overdose drug under certain circumstances. (An opioid is a drug with effects similar to opium, such as heroin.) The individuals exempted from liability are:

 a health care professional who prescribes or provides an opioid overdose drug to an individual at risk of experiencing an opioid overdose or to another individual in a position to assist the individual, if the individual has been educated about opioid overdose prevention and treatment by the health care professional or as part of a government opioid overdose program; an individual who provides an opioid overdose drug for emergency administration to another individual authorized to receive it as part of an opioid overdose program; and an individual who administers an opioid overdose drug to another individual who appears to have suffered an opioid overdose if the individual obtained the drug from a health care professional or as part of an opioid overdose program and was educated by the professional or program in the proper administration of the drug. These exemptions are inapplicable if the harm was caused by gross negligence or reckless misconduct.

States can preempt these exemptions by providing additional protections from liability for individuals that administer opioid overdose drugs, or by enacting legislation making the Act not applicable to state civil action involving only citizens from that state.

Date: 2015-04-15
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Breaking Addiction Act of 2015

This bill directs the Secretary of Health and Human Services to provide for waiver of the limitation on medical assistance to certain patients in an institution for mental diseases (IMD limitation) in order to permit medical assistance under title XIX (Medicaid) of the Social Security Act for the treatment of a substance use condition for a qualified individual in a community-based institution for mental diseases.

Date: 2015-04-23
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Medicare Patient Safety and Drug Abuse Prevention Act 

Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to authorize a prescription drug plan (PDP) sponsor to establish a drug management program for at-risk beneficiaries.

Requires a PDP sponsor, with respect to covered part D drugs, to have in place, directly or through appropriate arrangements, a utilization management tool designed to prevent: (1) the abuse of frequently abused drugs by individuals, and (2) the diversion of such drugs at pharmacies.

Directs the Department of Health and Human Services (HHS) to authorize Medicare drug integrity contractors (MEDICs) to accept directly an individual's prescription and necessary medical records from pharmacies, PDPs, and physicians in order for MEDICs to provide information relevant to determining whether the individual is an at-risk beneficiary.

Requires the Inspector General of HHS to study the effectiveness of MEDICs in identifying, combating, and preventing fraud under the Medicare program.

Expresses the sense of Congress that Medicare Advantage organizations and PDP sponsors should consider using e-prescribing and other health information technology tools to support combating fraud under MA-PD plans and prescription drug plans under parts C (Medicare+Choice) and D.

Date: 2015-05-13
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Dispose Responsibly of your Pills Act of 2015 or the DROP Act of 2015

Authorizes the Attorney General, in coordination with the Administrator of the Drug Enforcement Administration (DEA), the Secretary of Health and Human Services, and the Director of the Office of National Drug Control Policy, to make grants to eligible entities to expand or make available disposal sites for unwanted prescription medications.

Defines "eligible entity" to include:

 a state, local, or tribal law enforcement agency; a manufacturer, distributor, or reverse distributor of prescription medications; a retail pharmacy; a registered narcotic treatment program; a hospital or clinic with an on-site pharmacy; and an eligible long-term care facility. Requires a recipient to use a grant for:

 expenses of a prescription drug disposal site; implementing disposal procedures and processes and community education strategies; replicating a prescription drug take back initiative throughout multiple jurisdictions; and training of law enforcement officers and other community participants. Limits grants to not more than $250,000 for not longer than two years.

Directs the Attorney General to make a grant: (1) to provide technical assistance and training for a grant recipient, and (2) for evaluation of each recipient's performance. Requires recipients to report each fiscal year on: (1) the effectiveness of their prescription drug take back programs, and (2) the effect of disposal efforts on drug circulation.

Date: 2015-05-20
Topic: Health (Drug and Alcohol Abuse)
Subject: Crime and law enforcement
Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015

This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA), to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication.

This bill amends the Public Health Service Act to revise and extend through FY2020 the controlled substance monitoring program.

Government entities receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes.

A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the state's controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system. This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to extend the Edward Byrne Memorial Justice Assistance Grant Program through FY2020.

HHS must advance education and awareness of the risk of abuse of prescription opioids (drugs with effects similar to opium).

The Office of National Drug Control Policy (ONDCP), in coordination with HHS and the DEA, must establish a national drug awareness campaign that emphasizes the similarities between heroin and prescription opioids.

The DEA, in coordination with HHS and ONDCP, may make grants to state, local, or tribal governments to create demonstration programs to allow first responders to prevent opioid overdose death by administering an opioid overdose reversal drug (e.g., naloxone).

Date: 2015-06-17
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Stop Overdose Stat Act of 2015

This bill amends the Public Health Service Act to require the Substance Abuse and Mental Health Services Administration (SAMHSA) to enter into cooperative agreements to reduce deaths from drug overdoses by: (1) purchasing and distributing naloxone (a medication that rapidly reverses overdose from heroin or other drugs with effects similar to opium) or a similar drug; and (2) educating or training the public, first responders, or health professionals on drug overdose prevention or response.

SAMHSA must establish a coordinating center and develop a plan to reduce drug overdose deaths by educating the public about overdose prevention and recommending improvements to overdose prevention programs.

The Centers for Disease Control and Prevention must improve drug overdose surveillance by entering into cooperative agreements to: (1) provide training to improve identification of drug overdose as the cause of death, and (2) establish a national program for reporting drug overdoses.

The National Institute on Drug Abuse (NIDA) must prioritize, conduct, and support research on circumstances that contribute to drug overdose, drugs associated with fatal overdose, and overdose prevention methods. NIDA must support research on drug overdose treatments that can be administered by lay persons or first responders.

Date: 2015-06-23
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

DXM Abuse Prevention Act of 2015

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM, a cough suppressant and drug of abuse) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Retailers selling DXM must implement a verification system to ensure compliance. Civil monetary penalties that escalate upon repeated violation are imposed.

(Sec. 3) Unfinished DXM may only be possessed by, distributed to, and received by persons registered with the Food and Drug Administration as producers of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.

Date: 2015-07-28
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Expanding Opportunities for Recovery Act of 2015

This bill requires the Center for Substance Abuse Treatment in the Substance Abuse and Mental Health Services Administration to award grants to states to expand access to clinically appropriate services for opioid abuse or addiction. States must use these grants to provide up to 60 consecutive days of services to individuals who otherwise would not have access to substance abuse services.

Date: 2015-10-01
Topic: Health (Drug and Alcohol Abuse)
Subject: Health
Opioid Abuse Prevention and Treatment Act of 2015

This bill requires the Department of Health and Human Services (HHS) to award grants to states to develop a peer review process to identify and investigate questionable or inappropriate prescribing and dispensing patterns of drugs classified as schedule II or III under the Controlled Substances Act, which are drugs with an accepted medical use that have the potential to be abused and addictive.

This bill amends the Public Health Service Act to require HHS to establish grant programs to: (1) facilitate training to increase the capacity of health care providers to screen and treat patients to prevent drug abuse, and (2) develop continuing education criteria that allow health profession boards or state agencies to certify appropriate education for safe prescribing of schedule II or III drugs. The Health Resources and Services Administration must award grants to evaluate the prospect of state health professions boards expanding the authority of providers to prescribe drugs to treat drug abuse.

The Drug Enforcement Administration must request that practitioners registered to dispense controlled substances screen patients for potential drug abuse before prescribing a schedule II or III drug.

The Food and Drug Administration must consider whether naloxone (a prescription drug used to rapidly reverse an overdose of heroin or other opioids, which are drugs with effects similar to opium) should be available without a prescription.

HHS must convene or coordinate with an interagency working group to encourage states and local governments to increase opportunities for disposal of opiates (drugs derived from opium) and to reduce opportunities for abuse of opiates.

The Government Accountability Office must review federal opioid abuse activities and make recommendations to reduce opioid abuse and overdoses.

Date: 2015-10-01
Topic: Health (Drug and Alcohol Abuse)
Subject: Health